Related references
Note: Only part of the references are listed.Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS
Kumaran Deiva et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study
R. Lanzillo et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Factors associated with health care utilization in pediatric multiple sclerosis
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE
Ralf Gold et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Therapy of highly active pediatric multiple sclerosis
Peter Huppke et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Therapy of highly active pediatric multiple sclerosis
Peter Huppke et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Long-term disability progression of pediatric-onset multiple sclerosis
Kyla A. Mckay et al.
NEUROLOGY (2019)
Clinical trials of disease-modifying agents in pediatric MS Opportunities, challenges, and recommendations from the IPMSSG
Emmanuelle Waubant et al.
NEUROLOGY (2019)
Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis
Kyla A. McKay et al.
JAMA NEUROLOGY (2019)
Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis
A. Johnen et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2019)
A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries
Takahiko Saida et al.
BMC NEUROLOGY (2019)
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis
Antonio Carotenuto et al.
SCIENTIFIC REPORTS (2019)
Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)
Jenny Feng et al.
PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS (2019)
Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes
Jinny Min et al.
NEUROLOGY AND THERAPY (2019)
Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)
Raed Alroughani et al.
PEDIATRIC NEUROLOGY (2018)
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Tanuja Chitnis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
Ralf Gold et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
Ralf Gold et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Use of Disease-Modifying Therapies in Pediatric MS
Marta Simone et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2016)
International Pediatric MS Study Group Global Members Symposium report
Evangeline Wassmer et al.
NEUROLOGY (2016)
Pediatric multiple sclerosis Escalation and emerging treatments
Tanuja Chitnis et al.
NEUROLOGY (2016)
Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases
Amit Bar-Or et al.
NEUROLOGY (2016)
Pediatric multiple sclerosis Conventional first-line treatment and general management
Angelo Ghezzi et al.
NEUROLOGY (2016)
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study
Naila Makhani et al.
PEDIATRIC NEUROLOGY (2016)
Characterizing absolute lymphocyte count profiles in dimethyl fumarate-treated patients with MS Patient management considerations
Robert J. Fox et al.
NEUROLOGY-CLINICAL PRACTICE (2016)
Natalizumab in the pediatric MS population: results of the Italian registry
Angelo Ghezzi et al.
BMC NEUROLOGY (2015)
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research
Amy Waldman et al.
LANCET NEUROLOGY (2014)
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis
Riley Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
Russell C. Dale et al.
NEUROLOGY (2014)
Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years
L. A. Benson et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study
Katharine E. Harding et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
Lauren B. Krupp et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
The management of multiple sclerosis in children: a European view
Angelo Ghezzi et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Difference in Disease Burden and Activity in Pediatric Patients on Brain Magnetic Resonance Imaging at Time of Multiple Sclerosis Onset vs Adults
Emmanuelle Waubant et al.
ARCHIVES OF NEUROLOGY (2009)
Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
Mark P. Gorman et al.
ARCHIVES OF NEUROLOGY (2009)
Age- and Sex-Related Expression and Activity of Carboxylesterase 1 and 2 in Mouse and Human Liver
Hao-Jie Zhu et al.
DRUG METABOLISM AND DISPOSITION (2009)
Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis
Katherine A. McLaughlin et al.
JOURNAL OF IMMUNOLOGY (2009)
Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States
T. Chitnis et al.
MULTIPLE SCLEROSIS (2009)
Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes
Brenda Banwell et al.
ANNALS OF NEUROLOGY (2008)
Natural history of multiple sclerosis with childhood onset
Christel Renoux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of pediatric multiple sclerosis and variants
D. Pohl et al.
NEUROLOGY (2007)
Early onset multiple sclerosis - A longitudinal study
A Boiko et al.
NEUROLOGY (2002)
Share Paper
